25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

STENO (Stenocare) Stock Analysis
Buy, Hold or Sell?

Let's analyze Stenocare together

I guess you are interested in Stenocare AS. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Stenocare’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Stenocare’s Price Targets

I'm going to help you getting a better view of Stenocare AS. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Stenocare AS

I send you an email if I find something interesting about Stenocare AS.

1. Quick Overview

1.1. Quick analysis of Stenocare (30 sec.)










1.2. What can you expect buying and holding a share of Stenocare? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.06
Expected worth in 1 year
kr-0.45
How sure are you?
32.1%

+ What do you gain per year?

Total Gains per Share
kr-0.52
Return On Investment
-78.2%

For what price can you sell your share?

Current Price per Share
kr0.66
Expected price per share
kr0.45 - kr0.7
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Stenocare (5 min.)




Live pricePrice per Share (EOD)
kr0.66
Intrinsic Value Per Share
kr2.74 - kr3.42
Total Value Per Share
kr2.81 - kr3.48

2.2. Growth of Stenocare (5 min.)




Is Stenocare growing?

Current yearPrevious yearGrowGrow %
How rich?$380.6k$3.9m-$2.5m-176.7%

How much money is Stenocare making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m-$657.6k-$624.8k-48.7%
Net Profit Margin-506.5%-847.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Stenocare (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Stenocare?

Welcome investor! Stenocare's management wants to use your money to grow the business. In return you get a share of Stenocare.

First you should know what it really means to hold a share of Stenocare. And how you can make/lose money.

Speculation

The Price per Share of Stenocare is kr0.66. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Stenocare.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Stenocare, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.06. Based on the TTM, the Book Value Change Per Share is kr-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Stenocare.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.01-1.2%-0.03-5.1%-0.02-2.6%-0.02-3.4%-0.02-2.9%-0.01-2.1%
Usd Book Value Change Per Share0.023.7%-0.02-3.1%0.000.4%-0.01-1.8%0.00-0.3%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.023.7%-0.02-3.1%0.000.4%-0.01-1.8%0.00-0.3%0.000.1%
Usd Price Per Share0.06-0.30-0.70-0.83-1.41-1.01-
Price to Earnings Ratio-1.76--4.47--10.64--12.22--26.34--18.82-
Price-to-Total Gains Ratio2.38-37.01--9.17--19.79--76.21--76.21-
Price to Book Ratio5.78-2.87-6.99-8.06-9.44-6.75-
Price-to-Total Gains Ratio2.38-37.01--9.17--19.79--76.21--76.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.10329
Number of shares9681
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.00
Usd Total Gains Per Share-0.020.00
Gains per Quarter (9681 shares)-195.59-16.30
Gains per Year (9681 shares)-782.34-65.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-782-7920-65-75
20-1565-15740-130-140
30-2347-23560-196-205
40-3129-31380-261-270
50-3912-39200-326-335
60-4694-47020-391-400
70-5476-54840-456-465
80-6259-62660-522-530
90-7041-70480-587-595
100-7823-78300-652-660

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.026.00.07.1%2.026.00.07.1%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%5.015.00.025.0%9.019.00.032.1%9.019.00.032.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.028.00.0%0.00.028.00.0%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%5.015.00.025.0%9.019.00.032.1%9.019.00.032.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Stenocare AS compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.155-0.129+183%0.016+868%-0.074+148%-0.011+107%0.002+6699%
Book Value Per Share--0.0640.237-73%0.656-90%0.523-88%0.820-92%0.687-91%
Current Ratio--1.7421.082+61%1.239+41%1.720+1%6.965-75%6.420-73%
Debt To Asset Ratio--0.7390.628+18%0.297+149%0.415+78%0.277+167%0.305+143%
Debt To Equity Ratio--2.8380.922+208%0.424+570%0.613+363%0.399+611%0.512+454%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--7145114.60062450172.730-89%165989090.000-96%193488286.493-96%347049124.408-98%347049124.408-98%
Eps---0.052-0.215+311%-0.110+111%-0.145+178%-0.121+131%-0.089+71%
Ev To Sales Ratio--2.2859.506-76%64.932-96%78.875-97%-34.597+1614%-34.597+1614%
Free Cash Flow Per Share---0.098-0.046-53%-0.076-22%-0.063-36%-0.096-2%-0.094-5%
Free Cash Flow To Equity Per Share---0.098-0.032-67%0.005-2258%-0.025-74%-0.016-83%-0.002-98%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.416----------
Intrinsic Value_10Y_min--2.744----------
Intrinsic Value_1Y_max---0.165----------
Intrinsic Value_1Y_min---0.162----------
Intrinsic Value_3Y_max---0.108----------
Intrinsic Value_3Y_min---0.111----------
Intrinsic Value_5Y_max--0.414----------
Intrinsic Value_5Y_min--0.351----------
Market Cap25192992.000+44%14047001.60073804969.480-81%170529836.000-92%201429740.493-93%344312430.808-96%245937450.577-94%
Net Profit Margin---2.551-5.065+99%-8.472+232%-7.193+182%-2.714+6%-3.155+24%
Operating Margin---0.066-100%-7.7270%-5.0780%-1.5180%-2.2780%
Operating Ratio--3.3673.582-6%15.467-78%11.928-72%8.975-62%8.417-60%
Pb Ratio10.358+44%5.7762.865+102%6.990-17%8.055-28%9.445-39%6.746-14%
Pe Ratio-3.158-79%-1.761-4.466+154%-10.641+504%-12.223+594%-26.343+1396%-18.816+969%
Price Per Share0.660+44%0.3681.934-81%4.468-92%5.277-93%9.020-96%6.443-94%
Price To Free Cash Flow Ratio-1.682-79%-0.938-5.635+501%-15.329+1534%-20.143+2047%-24.134+2473%-17.239+1738%
Price To Total Gains Ratio4.266+44%2.37837.007-94%-9.165+485%-19.791+932%-76.207+3304%-76.207+3304%
Quick Ratio--0.1820.392-54%0.809-78%1.023-82%5.987-97%5.613-97%
Return On Assets---0.214-0.420+97%-0.119-44%-0.218+2%-0.156-27%-0.145-32%
Return On Equity---0.820-0.318-61%-0.170-79%-0.219-73%-0.159-81%-0.188-77%
Total Gains Per Share--0.155-0.129+183%0.016+868%-0.074+148%-0.011+107%0.002+6699%
Usd Book Value--380631.1621416754.280-73%3919805.264-90%3122288.776-88%4900718.585-92%4101299.107-91%
Usd Book Value Change Per Share--0.024-0.020+183%0.003+868%-0.012+148%-0.002+107%0.000+6699%
Usd Book Value Per Share--0.0100.037-73%0.103-90%0.082-88%0.128-92%0.107-91%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--1118210.4359773452.032-89%25977292.585-96%30280916.836-96%54313187.970-98%54313187.970-98%
Usd Eps---0.008-0.034+311%-0.017+111%-0.023+178%-0.019+131%-0.014+71%
Usd Free Cash Flow---585862.915-273239.806-53%-455637.259-22%-373725.896-36%-576347.149-2%-559144.294-5%
Usd Free Cash Flow Per Share---0.015-0.007-53%-0.012-22%-0.010-36%-0.015-2%-0.015-5%
Usd Free Cash Flow To Equity Per Share---0.015-0.005-67%0.001-2258%-0.004-74%-0.003-83%0.000-98%
Usd Market Cap3942703.248+44%2198355.75011550477.724-81%26687919.334-92%31523754.387-93%53884895.421-96%38489211.015-94%
Usd Price Per Share0.103+44%0.0580.303-81%0.699-92%0.826-93%1.412-96%1.008-94%
Usd Profit---312115.149-1282531.311+311%-657667.619+111%-868028.411+178%-720257.227+131%-533397.217+71%
Usd Revenue--122328.85172750.042+68%169776.012-28%138238.185-12%89226.667+37%87422.197+40%
Usd Total Gains Per Share--0.024-0.020+183%0.003+868%-0.012+148%-0.002+107%0.000+6699%
 EOD+6 -2MRQTTM+13 -23YOY+13 -223Y+14 -215Y+14 -2110Y+14 -21

3.3 Fundamental Score

Let's check the fundamental score of Stenocare AS based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.158
Price to Book Ratio (EOD)Between0-110.358
Net Profit Margin (MRQ)Greater than0-2.551
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.182
Current Ratio (MRQ)Greater than11.742
Debt to Asset Ratio (MRQ)Less than10.739
Debt to Equity Ratio (MRQ)Less than12.838
Return on Equity (MRQ)Greater than0.15-0.820
Return on Assets (MRQ)Greater than0.05-0.214
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Stenocare AS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.662
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Stenocare AS

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.

Fundamental data was last updated by Penke on 2025-07-02 21:46:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Stenocare earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compareΒ Stenocare to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -255.1%Β means thatΒ kr-2.55 for each kr1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Stenocare AS:

  • The MRQ is -255.1%. The company is making a huge loss. -2
  • The TTM is -506.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-255.1%TTM-506.5%+251.4%
TTM-506.5%YOY-847.2%+340.7%
TTM-506.5%5Y-271.4%-235.1%
5Y-271.4%10Y-315.5%+44.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Stenocare is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Stenocare to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -21.4% Return on Assets means thatΒ Stenocare generatedΒ kr-0.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Stenocare AS:

  • The MRQ is -21.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -42.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.4%TTM-42.0%+20.7%
TTM-42.0%YOY-11.9%-30.1%
TTM-42.0%5Y-15.6%-26.5%
5Y-15.6%10Y-14.5%-1.1%
4.3.1.3. Return on Equity

Shows how efficient Stenocare is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Stenocare to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -82.0% Return on Equity means Stenocare generated kr-0.82Β for eachΒ kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Stenocare AS:

  • The MRQ is -82.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -31.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-82.0%TTM-31.8%-50.2%
TTM-31.8%YOY-17.0%-14.8%
TTM-31.8%5Y-15.9%-15.9%
5Y-15.9%10Y-18.8%+2.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Stenocare AS.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Stenocare is operatingΒ .

  • Measures how much profit Stenocare makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Stenocare to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated kr0.00 Β for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Stenocare AS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM6.6%-6.6%
TTM6.6%YOY-772.7%+779.3%
TTM6.6%5Y-151.8%+158.4%
5Y-151.8%10Y-227.8%+76.0%
4.3.2.2. Operating Ratio

Measures how efficient Stenocare is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 3.37 means that the operating costs are kr3.37 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Stenocare AS:

  • The MRQ is 3.367. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.582. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.367TTM3.582-0.215
TTM3.582YOY15.467-11.885
TTM3.5825Y8.975-5.393
5Y8.97510Y8.417+0.557
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Stenocare AS.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Stenocare is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.74Β means the company has kr1.74 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Stenocare AS:

  • The MRQ is 1.742. The company is able to pay all its short-term debts. +1
  • The TTM is 1.082. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.742TTM1.082+0.660
TTM1.082YOY1.239-0.157
TTM1.0825Y6.965-5.883
5Y6.96510Y6.420+0.546
4.4.3.2. Quick Ratio

Measures if Stenocare is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Stenocare to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.18Β means the company can pay off kr0.18 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Stenocare AS:

  • The MRQ is 0.182. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.392. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.182TTM0.392-0.210
TTM0.392YOY0.809-0.417
TTM0.3925Y5.987-5.594
5Y5.98710Y5.613+0.373
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Stenocare AS.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of StenocareΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Stenocare to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.74Β means that Stenocare assets areΒ financed with 73.9% credit (debt) and the remaining percentage (100% - 73.9%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Stenocare AS:

  • The MRQ is 0.739. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.628. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.739TTM0.628+0.111
TTM0.628YOY0.297+0.332
TTM0.6285Y0.277+0.351
5Y0.27710Y0.305-0.027
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Stenocare is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Stenocare to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 283.8% means that company has kr2.84 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Stenocare AS:

  • The MRQ is 2.838. The company is unable to pay all its debts with equity. -1
  • The TTM is 0.922. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ2.838TTM0.922+1.916
TTM0.922YOY0.424+0.498
TTM0.9225Y0.399+0.523
5Y0.39910Y0.512-0.113
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every kr1 in earnings Stenocare generates.

  • Above 15 is considered overpriced butΒ always compareΒ Stenocare to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.76 means the investor is paying kr-1.76Β for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Stenocare AS:

  • The EOD is -3.158. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.761. Based on the earnings, the company is expensive. -2
  • The TTM is -4.466. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.158MRQ-1.761-1.397
MRQ-1.761TTM-4.466+2.705
TTM-4.466YOY-10.641+6.175
TTM-4.4665Y-26.343+21.877
5Y-26.34310Y-18.816-7.527
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Stenocare AS:

  • The EOD is -1.682. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.938. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.635. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.682MRQ-0.938-0.744
MRQ-0.938TTM-5.635+4.697
TTM-5.635YOY-15.329+9.693
TTM-5.6355Y-24.134+18.499
5Y-24.13410Y-17.239-6.895
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Stenocare is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 5.78 means the investor is paying kr5.78Β for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Stenocare AS:

  • The EOD is 10.358. Based on the equity, the company is expensive. -2
  • The MRQ is 5.776. Based on the equity, the company is overpriced. -1
  • The TTM is 2.865. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD10.358MRQ5.776+4.583
MRQ5.776TTM2.865+2.910
TTM2.865YOY6.990-4.125
TTM2.8655Y9.445-6.579
5Y9.44510Y6.746+2.698
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in DKK. All numbers in thousands.

Summary
Total Assets9,334
Total Liabilities6,902
Total Stockholder Equity2,432
 As reported
Total Liabilities 6,902
Total Stockholder Equity+ 2,432
Total Assets = 9,334

Assets

Total Assets9,334
Total Current Assets9,239
Long-term Assets95
Total Current Assets
Cash And Cash Equivalents 5,945
Net Receivables 964
Inventory 640
Total Current Assets  (as reported)9,239
Total Current Assets  (calculated)7,549
+/- 1,690
Long-term Assets
Property Plant Equipment 84
Long-term Assets  (as reported)95
Long-term Assets  (calculated)84
+/- 11

Liabilities & Shareholders' Equity

Total Current Liabilities5,304
Long-term Liabilities1,598
Total Stockholder Equity2,432
Total Current Liabilities
Short Long Term Debt 1,277
Accounts payable 1,197
Total Current Liabilities  (as reported)5,304
Total Current Liabilities  (calculated)2,475
+/- 2,829
Long-term Liabilities
Long term Debt 1,523
Capital Lease Obligations Min Short Term Debt45
Long-term Liabilities  (as reported)1,598
Long-term Liabilities  (calculated)1,567
+/- 31
Total Stockholder Equity
Total Stockholder Equity (as reported)2,432
Total Stockholder Equity (calculated)0
+/- 2,432
Other
Capital Stock3,072
Common Stock Shares Outstanding 38,171
Net Invested Capital 5,232
Net Working Capital 3,935
Property Plant and Equipment Gross 84



6.2. Balance Sheets Structured

Currency in DKK. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
794
4,751
21,711
23,805
29,759
36,669
31,608
28,100
59,987
57,732
56,340
53,492
51,066
47,147
43,936
44,875
40,800
37,328
39,604
33,148
39,146
34,509
38,121
30,745
26,796
26,270
19,436
9,334
9,33419,43626,27026,79630,74538,12134,50939,14633,14839,60437,32840,80044,87543,93647,14751,06653,49256,34057,73259,98728,10031,60836,66929,75923,80521,7114,7517940
   > Total Current Assets 
0
769
4,727
21,685
23,273
21,154
27,827
22,764
12,676
44,473
40,194
29,193
24,012
21,138
17,931
15,086
16,393
12,785
10,146
13,130
7,514
14,228
10,393
14,855
8,343
5,199
5,522
5,003
9,239
9,2395,0035,5225,1998,34314,85510,39314,2287,51413,13010,14612,78516,39315,08617,93121,13824,01229,19340,19444,47312,67622,76427,82721,15423,27321,6854,7277690
       Cash And Cash Equivalents 
0
203
2,587
18,147
17,408
17,925
24,791
21,725
11,325
41,152
37,605
26,360
20,422
15,914
14,561
11,720
9,992
6,394
3,395
4,429
1,934
6,962
5,090
9,498
2,619
154
52
1,381
5,945
5,9451,381521542,6199,4985,0906,9621,9344,4293,3956,3949,99211,72014,56115,91420,42226,36037,60541,15211,32521,72524,79117,92517,40818,1472,5872030
       Net Receivables 
0
0
1,406
3,050
5,593
1,300
0
0
0
0
430
105
1,981
3,407
1,315
1,835
1,680
4,561
633
3,625
720
2,136
1,162
2,146
2,072
2,891
3,630
1,293
964
9641,2933,6302,8912,0722,1461,1622,1367203,6256334,5611,6801,8351,3153,4071,98110543000001,3005,5933,0501,40600
       Other Current Assets 
0
572
488
404
5
679
3,036
1,039
1,351
3,321
2,589
1,376
1,609
1,817
2,054
1,530
1,977
1,801
1,639
1,666
1,516
4,203
4,010
1,394
1,742
1,664
1,491
0
0
001,4911,6641,7421,3944,0104,2031,5161,6661,6391,8011,9771,5302,0541,8171,6091,3762,5893,3211,3511,0393,03667954044885720
   > Long-term Assets 
0
25
24
26
532
8,606
8,842
8,844
15,423
15,514
17,538
27,148
29,480
29,928
29,216
28,850
28,482
28,014
27,182
26,474
25,633
24,918
24,116
23,267
22,402
21,597
20,748
14,433
95
9514,43320,74821,59722,40223,26724,11624,91825,63326,47427,18228,01428,48228,85029,21629,92829,48027,14817,53815,51415,4238,8448,8428,6065322624250
       Property Plant Equipment 
0
19
18
20
59
8,132
8,368
8,356
14,929
15,021
17,045
26,655
28,987
29,435
28,723
28,357
27,989
27,521
26,688
25,980
25,139
24,424
23,621
22,773
21,924
21,119
20,270
13,955
84
8413,95520,27021,11921,92422,77323,62124,42425,13925,98026,68827,52127,98928,35728,72329,43528,98726,65517,04515,02114,9298,3568,3688,132592018190
       Other Assets 
0
0
0
0
0
0
0
0
0
0
16,475
493
493
493
493
493
493
493
494
494
494
0
0
0
0
0
0
0
0
0000000049449449449349349349349349349316,4750000000000
> Total Liabilities 
0
449
1,011
1,238
2,128
9,519
19,777
18,134
17,454
1,298
1,223
3,770
3,698
3,395
2,237
3,693
8,379
9,066
9,897
15,462
13,444
10,493
10,939
12,299
8,602
8,381
7,432
22,910
6,902
6,90222,9107,4328,3818,60212,29910,93910,49313,44415,4629,8979,0668,3793,6932,2373,3953,6983,7701,2231,29817,45418,13419,7779,5192,1281,2381,0114490
   > Total Current Liabilities 
0
449
1,011
1,238
2,128
9,519
19,777
18,134
17,454
1,298
1,223
3,690
3,698
3,395
1,224
2,390
1,649
2,168
3,176
9,612
8,321
9,337
9,889
11,363
7,775
7,666
4,543
7,229
5,304
5,3047,2294,5437,6667,77511,3639,8899,3378,3219,6123,1762,1681,6492,3901,2243,3953,6983,6901,2231,29817,45418,13419,7779,5192,1281,2381,0114490
       Short-term Debt 
0
0
0
0
0
0
15,675
0
17,025
0
0
0
0
553
250
255
321
416
416
6,188
6,113
7,295
9,255
9,884
6,022
6,314
858
0
0
008586,3146,0229,8849,2557,2956,1136,188416416321255250553000017,025015,675000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,686
5,773
6,865
6,959
8,308
5,675
5,974
401
1,047
1,277
1,2771,0474015,9745,6758,3086,9596,8655,7735,6860000000000000000000
       Accounts payable 
0
361
926
603
1,253
8,700
513
816
119
600
124
1,442
3,036
2,086
244
1,188
943
1,388
1,934
2,511
1,651
1,399
633
1,479
1,329
615
802
2,635
1,197
1,1972,6358026151,3291,4796331,3991,6512,5111,9341,3889431,1882442,0863,0361,4421246001198165138,7001,2536039263610
       Other Current Liabilities 
0
88
85
635
876
818
3,589
16,635
309
698
1,099
2,248
662
756
730
1,262
385
363
827
1,966
557
643
0
-108
425
736
2,883
0
0
002,883736425-10806435571,9668273633851,2627307566622,2481,09969830916,6353,58981887663585880
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
80
40
0
1,014
1,303
6,730
6,898
6,721
5,850
5,123
1,156
1,050
936
826
716
2,889
15,681
1,598
1,59815,6812,8897168269361,0501,1565,1235,8506,7216,8986,7301,3031,0140408000000000000
> Total Stockholder Equity
0
346
3,740
20,472
21,677
20,241
16,892
13,475
10,646
58,689
56,509
52,571
49,794
47,670
44,910
40,243
36,496
31,734
27,431
24,143
19,703
28,652
23,570
25,822
22,143
18,415
18,838
-3,474
2,432
2,432-3,47418,83818,41522,14325,82223,57028,65219,70324,14327,43131,73436,49640,24344,91047,67049,79452,57156,50958,68910,64613,47516,89220,24121,67720,4723,7403460
   Common Stock
0
500
543
715
715
715
715
715
715
934
934
934
934
934
934
934
934
934
934
934
934
1,208
1,208
1,471
1,471
1,471
1,617
0
0
001,6171,4711,4711,4711,2081,2089349349349349349349349349349349349347157157157157157155435000
   Retained Earnings Total Equity00000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000
   Capital Surplus 00000000000000000000000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
1,500
5,124
23,033
23,033
23,033
23,033
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000023,03323,03323,03323,0335,1241,5000



6.3. Balance Sheets

Currency in DKK. All numbers in thousands.




6.4. Cash Flows

Currency in DKK. All numbers in thousands.




6.5. Income Statements

Currency in DKK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in DKK. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,232
Cost of Revenue-20,706
Gross Profit-18,474-18,474
 
Operating Income (+$)
Gross Profit-18,474
Operating Expense-35,324
Operating Income-33,092-53,798
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense35,3240
 
Net Interest Income (+$)
Interest Income31
Interest Expense-1,535
Other Finance Cost-0
Net Interest Income-1,505
 
Pretax Income (+$)
Operating Income-33,092
Net Interest Income-1,505
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-34,597-33,092
EBIT - interestExpense = -1,535
-34,488
-32,953
Interest Expense1,535
Earnings Before Interest and Taxes (EBIT)0-33,061
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-34,597
Tax Provision--108
Net Income From Continuing Ops-34,488-34,488
Net Income-34,488
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,505
 

Technical Analysis of Stenocare
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Stenocare. The general trend of Stenocare is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Stenocare's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Stenocare Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Stenocare AS.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.6368 < 0.68 < 0.7.

The bearish price targets are: 0.468 > 0.452 > 0.45.

Know someone who trades $STENO? Share this with them.πŸ‘‡

Stenocare AS Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Stenocare AS. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Stenocare AS Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Stenocare AS.

Stenocare AS Daily Moving Average Convergence/Divergence (MACD) ChartStenocare AS Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Stenocare AS. The current adx is .

Stenocare AS Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Stenocare AS.

Stenocare AS Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Stenocare AS.

Stenocare AS Daily Relative Strength Index (RSI) ChartStenocare AS Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Stenocare AS.

Stenocare AS Daily Stochastic Oscillator ChartStenocare AS Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Stenocare AS.

Stenocare AS Daily Commodity Channel Index (CCI) ChartStenocare AS Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Stenocare AS.

Stenocare AS Daily Chande Momentum Oscillator (CMO) ChartStenocare AS Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Stenocare AS.

Stenocare AS Daily Williams %R ChartStenocare AS Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Stenocare AS.

Stenocare AS Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Stenocare AS.

Stenocare AS Daily Average True Range (ATR) ChartStenocare AS Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Stenocare AS.

Stenocare AS Daily On-Balance Volume (OBV) ChartStenocare AS Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Stenocare AS.

Stenocare AS Daily Money Flow Index (MFI) ChartStenocare AS Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Stenocare AS.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Stenocare AS Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Stenocare AS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.662
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Stenocare with someone you think should read this too:
  • Are you bullish or bearish on Stenocare? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Stenocare? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Stenocare AS

I send you an email if I find something interesting about Stenocare AS.


Comments

How you think about this?

Leave a comment

Stay informed about Stenocare AS.

Receive notifications about Stenocare AS in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.